2021-01-05,Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial
2020-11-30,Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Invest In Growth?
2020-11-09,Marker Therapeutics Reports Third Quarter 2020 Operating and Financial Results
2020-11-09,"Marker Therapeutics, Inc. to Host Earnings Call"
2020-11-02,"Marker Therapeutics to Host Third Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, November 9, 2020"
2020-09-17,Marker Therapeutics to Present at the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
2020-08-10,Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results
2020-06-30,Marker Therapeutics Announces New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
2020-06-23,"Marker Therapeutics Receives USAN Approval for ""zelenoleucel"" as Nonproprietary Name for MT-401, Multi-Tumor-Associated Antigen Targeted T Cell Product for Acute Myeloid Leukemia"
2020-06-10,"Hedge Funds Never Been Less Bullish On Marker Therapeutics, Inc. (MRKR)"
2020-06-02,We're Not Very Worried About Marker Therapeutics's (NASDAQ:MRKR) Cash Burn Rate
2020-05-29,Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
2020-05-13,­­­­­­­­­Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting
2020-05-11,Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results
2020-05-04,"Marker Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, May 11, 2020"
2020-04-30,Penny Stocks to Buy Using Technical Analysis for May 2020
2020-04-29,Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
2020-04-11,"Coronavirus update: 1.72 million cases worldwide, 106,469 deaths; U.S. surpasses Italy in number of fatalities"
2020-04-10,FDA grants emergency authorization to two blood purification systems
2020-03-12,Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
2020-03-02,Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
2020-02-18,Marker Therapeutics to Present at Two Upcoming Investor Conferences
2020-02-11,Marker Therapeutics Announces Update to its Clinical Program in AML
2020-01-06,Such Is Life: How Marker Therapeutics (NASDAQ:MRKR) Shareholders Saw Their Shares Drop 58%
2019-12-17,"Is Marker Therapeutics, Inc. (MRKR) Going To Burn These Hedge Funds ?"
2019-11-25,Marker Therapeutics to Present at Two Upcoming Investor Conferences
2019-11-12,Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results
2019-11-11,"Marker Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast on Tuesday, November 12, 2019"
2019-11-07,"Hedge Funds Are Selling Marker Therapeutics, Inc. (MRKR)"
2019-10-08,We Think Marker Therapeutics (NASDAQ:MRKR) Can Afford To Drive Business Growth
2019-08-15,"Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs"
2019-08-08,Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
2019-08-08,"Do Insiders Own Shares In Marker Therapeutics, Inc. (NASDAQ:MRKR)?"
2019-08-06,Marker Therapeutics Appoints Steve Elms to its Board of Directors
2019-07-20,Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
2019-07-17,Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma
2019-06-28,"Hedge Funds Have Never Been This Bullish On Marker Therapeutics, Inc. (MRKR)"
2019-06-20,Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
2019-06-13,Will Marker Therapeutics Surge Higher?
2019-05-21,Marker Therapeutics to Present at Two Upcoming Investor Conferences
2019-05-10,Should Marker Therapeutics (NASDAQ:MRKR) Be Disappointed With Their 89% Profit?
2019-05-09,"MARKER THERAPEUTICS, INC. (MRKR) Reports Q1 Loss, Lags Revenue Estimates"
2019-05-09,Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results
2019-05-07,Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
2019-04-17,Here's Why Marker Therapeutics Fell as Much as 11.5% Today
2019-03-29,"Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker &amp; Dunlop, Marker Therapeutics, Chemed and Olympic Steel"
2019-03-28,Marker Therapeutics Provides Business and Clinical Update
2019-03-28,These 5 Stocks Make Great Buys on New Analyst Coverage
2019-03-18,"Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th"
2019-02-25,Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
2019-02-21,"Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award"
2019-02-20,Marker Therapeutics to Present at the CAR-TCR Summit Europe
2019-02-15,Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility
2019-02-07,"Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development"
2019-02-06,Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference
2019-02-04,"Does Market Volatility Impact Marker Therapeutics, Inc.s (NASDAQ:MRKR) Share Price?"
2019-01-17,Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019
2019-01-15,The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
2019-01-03,Marker Therapeutics Provides Updates of its Lead Clinical Programs
2018-12-31,These 4 Healthcare Stocks May Test December Highs
2018-12-06,Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit
2018-11-27,The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
2018-11-27,"Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer"
2018-11-08,Marker Therapeutics to Present at Three Upcoming Healthcare Conferences
2018-10-23,"Marker Therapeutics, Inc. Announces New Executive Appointments"
2018-10-22,True Nature Holding Inc. Strengthens Board of Advisors With Appointment of Michael J. Loiacono
2018-10-18,Marker to Present at Two Upcoming Cellular Therapy Conferences
